Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Year-end Financial Results on June 15, 2018
11. Juni 2018 07:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals and SunGen Pharma File ANDA for Extended-Release CNS Stimulant
30. Mai 2018 07:30 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche...
Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP
02. Januar 2018 12:56 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche...
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
04. Mai 2016 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 04, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today that its Board of Directors has appointed Davis S. Caskey to...
Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014
10. Februar 2014 15:26 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...